e.l.f. Beauty ELF Balance Sheet Statement
| TTM Q4 '26 | TTM Q3 '26 | TTM Q2 '26 | TTM Q1 '26 | TTM Q4 '25 | ||
|---|---|---|---|---|---|---|
| $289.69M+94.8% | $196.82M+167% | $199.4M+106% | $170.03M+55.9% | $148.69M+37.4% | ||
| $174.64M+38.6% | $190.3M+1.4% | $154.69M+5.5% | $173.35M+11.3% | $126.01M+1.8% | ||
| $220.25M+17.7% | $220.62M+2.7% | $247.39M+3.6% | $170.38M-14.6% | $187.17M-2.3% | ||
| $789.37M+46.0% | $701.59M+25.5% | $707.24M+27.7% | $602.53M+13.6% | $540.56M+13.3% | ||
| $41.5M+44.1% | $44.84M+126% | $44.42M+185% | $39.18M+179% | $28.79M+106% | ||
| $853.48M+151% | $852.77M+150% | $851.83M+150% | $340.58M0.0% | $340.58M0.0% | ||
| $553.11M+166% | $500.44M+238% | $511.58M+235% | $139.55M-11.1% | $207.7M-7.7% | ||
| $2.39B+91.8% | $2.32B+83.7% | $2.32B+87.4% | $1.31B+9.1% | $1.25B+10.5% | ||
| $97.47M+35.0% | $73.98M+13.3% | $109.3M+16.7% | $74.6M-6.7% | $72.18M-11.0% | ||
| $30M— | $30M-70.1% | $22.5M-77.6% | $0-100% | $0-100% | ||
| $336.16M+89.9% | $254.3M-13.5% | $261.87M-15.8% | $184.74M-38.4% | $177.06M-40.8% | ||
| $809.35M+215% | $846.7M+233% | $854.05M+232% | $256.68M-2.1% | $256.68M-2.1% | ||
| $1.26B+159% | $1.16B+134% | $1.18B+132% | $510.04M+1.8% | $487.32M+0.1% | ||
| $590K+6.1% | $250M0.0% | $250M0.0% | $250M0.0% | $556K+0.2% | ||
| -$155.93M+14.4% | -$106.56M+49.4% | -$145.94M+35.9% | -$148.94M+39.6% | -$182.25M+38.1% | ||
| $1.13B+48.6% | $1.16B+51.4% | $1.14B+56.5% | $804.85M+14.4% | $760.86M+18.4% | ||
| $2.39B+91.8% | $2.32B+83.7% | $2.32B+87.4% | $1.31B+9.1% | $1.25B+10.5% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Can e.l.f. Beauty cover its short-term obligations?
- Its current ratio is 2.35 — current assets exceed current liabilities.
- Where does e.l.f. Beauty's balance sheet data come from?
- Every line is extracted from e.l.f. Beauty's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.